Clinical research blog

Patient retention remains one of the most persistent constraints in clinical trial execution. When a significant proportion of enrolled patients drop out before...

MASH (Metabolic dysfunction-associated steatohepatitis) is a chronic liver disease that has gained significant attention from the pharmaceutical industry and cl...

Decentralized and hybrid clinical trials hold significant promise for improving access and reducing patient burden. But implementing them introduces operational...

In this webinar, Patrick Short (Co-Founder and CEO at Sano Genetics) and Will Jones (Co-Founder and CTO at Sano Genetics) discuss the technical challenges of bi...

Recruitment remains one of the most consequential operational challenges in clinical research. This article examines the structural factors that drive enrollmen...

Virtual and decentralized trial models have moved from emergency workaround to strategic default for many precision medicine programs. This article examines whe...

Sano Genetics supports personalised medicine research by increasing participation in clinical trials and guiding patients through the process Half of clinical t...

Clinical trials increasingly depend on genomic data to identify the right patients, reduce variability in treatment response, and accelerate the path to approva...